Mesenchymal GBM spheroid patient-derived cultures 022 and 067 did not increase proliferation in response to nAChR antagonists on either FBS-supplemented or serum-free medium (Figure 9D,E). This evidence concerns the gene CHRNA4 and glioblastoma.